Dostarlimab

Basic Information

Item Value
DrugBank ID DB15627
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 congenital pulmonary venous return anomaly KG + DL
2 Hunter-Macdonald syndrome KG + DL
3 arthrogryposis-like hand anomaly-sensorineural deafness syndrome KG + DL
4 X-linked lymphoproliferative disease due to XIAP deficiency KG + DL
5 malignant mesothelioma (disease) KG + DL
6 hypouricemia, hypercalcinuria, and decreased bone density KG + DL
7 Nijmegen breakage syndrome KG + DL
8 retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome KG + DL
9 infantile choroidocerebral calcification syndrome KG + DL
10 Charcot-Marie-Tooth disease, axonal, autosomal recessive KG + DL
11 medullary cystic kidney disease KG + DL
12 alpha 1-antitrypsin deficiency KG + DL
13 Pierpont syndrome KG + DL
14 glaucoma with elevated episcleral venous pressure KG + DL
15 inherited organic acidemia KG + DL
16 brain cancer KG + DL
17 lip disease KG + DL
18 pineal gland cancer KG + DL
19 central nervous system germ cell tumor KG + DL
20 placenta praevia KG + DL
21 malignant endocrine neoplasm KG + DL
22 secondary neoplasm KG + DL
23 myofibroblastoma KG + DL
24 peritoneal neoplasm KG + DL
25 vascular occlusion disorder KG + DL
26 nervous system disorder KG + DL
27 sweat gland neoplasm KG + DL
28 colorectal carcinoma KG + DL
29 benign neoplasm of small intestine KG + DL
30 blood vessel neoplasm KG + DL
31 conjunctival cancer KG + DL
32 colorectal lymphoma KG + DL
33 adenosarcoma KG + DL
34 benign neoplasm of thymus KG + DL
35 thyroid tumor KG + DL
36 thalamic cancer KG + DL
37 peritoneal mesothelioma (disease) KG + DL
38 pancreatic exocrine neoplasm KG + DL
39 neuritis of upper limb KG + DL
40 neoplasm of jaw KG + DL
41 disease of visual system KG + DL
42 vulvar squamous neoplasm KG + DL
43 vaginal cancer KG + DL
44 bone sarcoma KG + DL
45 yolk sac tumor KG + DL
46 developmental defect during embryogenesis KG + DL
47 alopecia KG + DL
48 fallopian tube neoplasm KG + DL
49 leiomyosarcoma KG + DL
50 eye neoplasm KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.